Geneos Wealth Management’s First Trust Active Factor Mid Cap ETF AFMC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.53M Buy
86,256
+3,506
+4% +$137K 0.07% 277
2026
Q1
$2.94M Sell
82,750
-4,767
-5% -$173K 0.07% 296
2025
Q4
$3.02M Buy
87,517
+2,235
+3% +$76.2K 0.07% 291
2025
Q3
$2.93M Buy
85,282
+80,632
+1,734% +$2.67M 0.07% 285
2025
Q2
$149K Buy
4,650
+813
+21% +$24.9K ﹤0.01% 1104
2025
Q1
$117K Buy
+3,837
New +$122K ﹤0.01% 1098

Other funds holding AFMC

Geneos Wealth Management's AFMC Position: Q2 2026 in Review

Geneos Wealth Management increased its First Trust Active Factor Mid Cap ETF (AFMC) stake by 4.2% in Q2 2026, buying an estimated $137K and bringing the position to 86,256 shares worth $3.53M. The position accounts for 0.07% of the portfolio, ranked #277.

Geneos Wealth Management first reported a position in AFMC in Q1 2025 and has held it in 6 quarters since. 50 funds tracked by Wall St. Rank hold AFMC as of Q2 2026.

  • Geneos Wealth Management held 86,256 shares of First Trust Active Factor Mid Cap ETF worth $3.53M as of Q2 2026.
  • Geneos Wealth Management bought 3,506 First Trust Active Factor Mid Cap ETF shares in Q2 2026, an estimated $137K.
  • First Trust Active Factor Mid Cap ETF made up 0.07% of Geneos Wealth Management's portfolio in Q2 2026, its #277 holding.
  • Geneos Wealth Management first reported a position in First Trust Active Factor Mid Cap ETF in Q1 2025 and has held it in 6 quarters since.
  • 50 funds tracked by Wall St. Rank held First Trust Active Factor Mid Cap ETF as of Q2 2026.

Based on Geneos Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.